Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap 438 Cr
P/E 27.70
Div Yield 0.10 %
Book Value βΉ706.00
52w High βΉ1,778.00
52w Low βΉ1,084.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
67.83
63.38
80.72
77.84
79.04
85.43
82.88
78.50
86.57
86.37
71.23
67.84
74.56
Expenses
58.19
57.18
69.16
67.04
68.21
79.83
69.81
66.71
72.80
75.56
62.21
58.36
69.43
Operating Profit
9.64
6.20
11.56
10.80
10.83
5.60
13.07
11.79
13.77
10.81
9.02
9.48
5.13
OPM %
14.21
9.78
14.32
13.87
13.70
6.56
15.77
15.02
15.91
12.52
12.66
13.97
6.88
Other Income
0.46
0.97
0.08
0.44
1.01
2.20
0.06
1.26
0.43
2.28
0.64
0.33
0.58
Depreciation
3.01
2.66
2.69
2.68
2.63
2.62
2.56
2.57
2.50
2.62
2.55
2.55
2.53
Interest
1.81
1.34
1.46
1.51
1.73
1.84
1.96
1.92
2.16
2.56
2.04
2.48
1.82
Profit before tax
5.28
3.17
7.49
7.05
7.48
3.34
8.61
8.56
9.54
7.91
5.07
4.78
1.36
Tax %
38.64
29.65
27.77
29.36
31.02
19.76
27.64
29.79
32.29
24.91
34.71
34.73
48.53
Net Profit
3.24
2.23
5.41
4.98
5.16
2.68
6.23
6.01
6.46
5.93
3.31
3.12
0.70
EPS in Rs
10.72
7.38
17.89
16.47
17.07
8.86
20.61
19.88
21.37
19.61
10.95
10.32
2.32
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
301.00 333.00 300.00 315.00 346.00 260.00 257.00 344.00 213.00 218.00 0.00 0.00
Expenses
261.00 289.00 265.00 289.00 314.00 230.00 233.00 312.00 200.00 189.00 0.00 0.00
Operating Profit
40.00 44.00 35.00 26.00 31.00 30.00 24.00 33.00 13.00 28.00 0.00 0.00
OPM %
13.00 13.00 12.00 8.00 9.00 11.00 9.00 9.00 6.00 13.00 β β
Other Income
1.00 4.00 4.00 5.00 14.00 1.00 2.00 2.00 3.00 2.00 0.00 0.00
Interest
6.00 8.00 9.00 5.00 5.00 5.00 5.00 5.00 4.00 6.00 0.00 0.00
Depreciation
11.00 10.00 10.00 8.00 8.00 7.00 7.00 6.00 6.00 6.00 0.00 0.00
Profit before tax
25.00 30.00 19.00 18.00 33.00 19.00 13.00 24.00 6.00 18.00 0.00 0.00
Tax %
29.00 29.00 32.00 28.00 23.00 32.00 31.00 30.00 -2.00 30.00 β β
Net Profit
18.00 21.00 13.00 13.00 25.00 13.00 9.00 17.00 6.00 13.00 0.00 0.00
EPS in Rs
58.81 70.68 43.23 43.73 83.95 43.56 30.26 55.01 21.50 β β β
Dividend Payout %
3.00 2.00 3.00 3.00 2.00 3.00 0.00 3.00 0.00 0.00 β β
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 0.01 0.01 0.01
Reserves
212.00 194.00 173.00 161.00 148.00 123.00 110.00 102.00 85.00 82.00 0.00 0.00
Borrowings
95.00 82.00 92.00 87.00 62.00 45.00 50.00 47.00 27.00 26.00 0.00 0.00
Other Liabilities
94.00 80.00 80.00 86.00 99.00 101.00 66.00 98.00 61.00 67.00 0.00 0.00
Total Liabilities
403.00 358.00 348.00 337.00 312.00 272.00 229.00 251.00 177.00 175.00 0.00 0.00
Fixed Assets
190.00 150.00 138.00 140.00 99.00 101.00 94.00 88.00 69.00 73.00 0.00 0.00
CWIP
1.00 0.00 6.00 1.00 21.00 3.00 2.00 1.00 7.00 0.00 0.00 0.00
Investments
23.00 23.00 23.00 23.00 23.00 26.00 26.00 26.00 5.00 0.00 0.00 0.00
Other Assets
189.00 184.00 181.00 174.00 169.00 142.00 106.00 135.00 95.00 102.00 0.00 0.00
Total Assets
403.00 358.00 348.00 337.00 312.00 272.00 229.00 251.00 177.00 175.00 0.00 0.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
38.00 28.00 15.00 5.00 -15.00 22.00 14.00 27.00 8.00 20.00 0.00 0.00
Cash from Investing Activity
-49.00 -14.00 -14.00 -28.00 -7.00 -6.00 -13.00 -43.00 -7.00 -8.00 0.00 0.00
Cash from Financing Activity
11.00 -14.00 -1.00 23.00 15.00 -8.00 -2.00 18.00 -1.00 -12.00 0.00 0.00
Net Cash Flow
0.00 0.00 0.00 -1.00 -8.00 8.00 -1.00 2.00 0.00 0.00 0.00 0.00
Free Cash Flow
-11.00 14.00 1.00 -24.00 -30.00 14.00 1.00 5.00 4.00 12.00 0.00 0.00
CFO/OP %
111.00 82.00 51.00 31.00 -23.00 88.00 70.00 103.00 66.00 87.00 β β
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2015
Debtor Days
66.00 71.00 60.00 53.00 36.00 42.00 31.00 39.00 46.00 65.00 β
Inventory Days
183.00 131.00 168.00 154.00 143.00 154.00 138.00 117.00 135.00 133.00 β
Days Payable
141.00 99.00 111.00 105.00 124.00 147.00 91.00 133.00 122.00 168.00 β
Cash Conversion Cycle
108.00 102.00 116.00 102.00 54.00 48.00 78.00 23.00 60.00 30.00 β
Working Capital Days
57.00 57.00 61.00 65.00 44.00 31.00 27.00 20.00 41.00 43.00 β
ROCE %
11.00 14.00 11.00 9.00 13.00 14.00 12.00 22.00 9.00 46.00 0.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
72.10
72.10
71.79
71.40
71.40
71.40
71.40
71.40
71.40
71.19
70.68
70.32
FIIs
0.00
0.00
0.00
0.00
0.03
0.00
0.00
0.02
0.01
0.00
0.00
0.00
DIIs
0.31
0.30
0.29
0.03
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Public
27.58
27.59
27.91
28.57
28.56
28.60
28.59
28.57
28.59
28.81
29.31
29.68
No. of Shareholders
6,859
6,937
7,125
7,521
7,412
7,479
7,626
7,849
7,861
8,116
8,233
8,443
Corporate Actions
7 records
Back to all stocks